436 related articles for article (PubMed ID: 16203993)
1. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract][Full Text] [Related]
2. HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand.
Malathi K; Paranjape JM; Ganapathi R; Silverman RH
Cancer Res; 2004 Dec; 64(24):9144-51. PubMed ID: 15604285
[TBL] [Abstract][Full Text] [Related]
3. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
[TBL] [Abstract][Full Text] [Related]
4. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
Malathi K; Dong B; Gale M; Silverman RH
Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
[TBL] [Abstract][Full Text] [Related]
5. The 2-5A system in viral infection and apoptosis.
Castelli J; Wood KA; Youle RJ
Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
[TBL] [Abstract][Full Text] [Related]
6. RNase L plays a role in the antiviral response to West Nile virus.
Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
[TBL] [Abstract][Full Text] [Related]
7. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
[TBL] [Abstract][Full Text] [Related]
8. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase.
Li G; Xiang Y; Sabapathy K; Silverman RH
J Biol Chem; 2004 Jan; 279(2):1123-31. PubMed ID: 14570908
[TBL] [Abstract][Full Text] [Related]
9. Identification of cellular genes induced in human cells after activation of the OAS/RNaseL pathway by vaccinia virus recombinants expressing these antiviral enzymes.
Domingo-Gil E; González JM; Esteban M
J Interferon Cytokine Res; 2010 Mar; 30(3):171-88. PubMed ID: 20038200
[TBL] [Abstract][Full Text] [Related]
10. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.
Birdwell LD; Zalinger ZB; Li Y; Wright PW; Elliott R; Rose KM; Silverman RH; Weiss SR
J Virol; 2016 Jan; 90(6):3160-72. PubMed ID: 26739051
[TBL] [Abstract][Full Text] [Related]
11. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity.
Asthana A; Gaughan C; Dong B; Weiss SR; Silverman RH
mBio; 2021 Aug; 12(4):e0178121. PubMed ID: 34372695
[TBL] [Abstract][Full Text] [Related]
12. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta.
Rusch L; Zhou A; Silverman RH
J Interferon Cytokine Res; 2000 Dec; 20(12):1091-100. PubMed ID: 11152576
[TBL] [Abstract][Full Text] [Related]
13. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L.
Park IH; Kwon YC; Ryu WS; Ahn BY
Antiviral Res; 2014 Apr; 104():118-27. PubMed ID: 24509240
[TBL] [Abstract][Full Text] [Related]
15. RNase L dimerization in a mammalian two-hybrid system in response to 2',5'-oligoadenylates.
Naik S; Paranjape JM; Silverman RH
Nucleic Acids Res; 1998 Mar; 26(6):1522-7. PubMed ID: 9490801
[TBL] [Abstract][Full Text] [Related]
16. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
[TBL] [Abstract][Full Text] [Related]
17. Impact of RNase L overexpression on viral and cellular growth and death.
Zhou A; Paranjape JM; Hassel BA; Nie H; Shah S; Galinski B; Silverman RH
J Interferon Cytokine Res; 1998 Nov; 18(11):953-61. PubMed ID: 9858317
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule activators of RNase L with broad-spectrum antiviral activity.
Thakur CS; Jha BK; Dong B; Das Gupta J; Silverman KM; Mao H; Sawai H; Nakamura AO; Banerjee AK; Gudkov A; Silverman RH
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9585-90. PubMed ID: 17535916
[TBL] [Abstract][Full Text] [Related]
19. Diverse functions of RNase L and implications in pathology.
Bisbal C; Silverman RH
Biochimie; 2007; 89(6-7):789-98. PubMed ID: 17400356
[TBL] [Abstract][Full Text] [Related]
20. Characterization of RNABP, an RNA binding protein that associates with RNase L.
Le Roy F; Laskowska A; Silhol M; Salehzada T; Bisbal C
J Interferon Cytokine Res; 2000 Jul; 20(7):635-44. PubMed ID: 10926206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
